Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.

International journal of geriatric psychiatry - 1 Feb 2008

Freund-Levi Yvonne, Basun Hans, Cederholm Tommy, Faxén-Irving Gerd, Garlind Anita, Grut Mikaela, Vedin Inger, Palmblad Jan, Wahlund Lars-Olof, Eriksdotter-Jönhagen Maria

Abstract excerpt

BACKGROUND: Epidemiological and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty acids (omega3), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), may have effects in psychiatric and behavioral symptoms in Alzheimer's disease (AD). An association with APOEomega4 carriers and neuropsychiatric symptoms in AD has also been suggested. OBJECTIVE: To determine effects of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activities of Daily Living
Share to Cholinesterase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dietary Supplements

Share to Double-Blind Method

Share to Fatty Acids, Omega-3

Share to Indans

Share to Piperidines

Share to Psychiatric Status Rating Scales

Source

Identifiers

PMID: 17582225
DOI: 10.1002/gps.1857

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.PMID 17582225Read ↗

Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.Semantic proximity Read ↗

Eicosanoid Lipidome Activation in the APOE4 Brain with DementiaSemantic proximity Read ↗

Omega-3 polyunsaturated fatty acids and brain health: Preclinical evidence for the prevention of neurodegenerative diseasesSemantic proximity Read ↗

The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case-control study.Semantic proximity Read ↗

A Scoping Review of Dietary Factors Conferring Risk or Protection for Cognitive Decline in APOE ε4 Carriers.Semantic proximity Read ↗

Use of fish oil supplements is differently related to incidence of all-cause and vascular dementia among people with the distinct APOE ε4 dosage.Semantic proximity Read ↗

Omega 3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical TrialsSemantic proximity Read ↗

Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.Semantic proximity Read ↗

A gene-environment interplay between omega-3 supplementation and APOE ε4 provides insights for Alzheimer's disease precise prevention amongst high-genetic-risk population.Semantic proximity Read ↗

Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.Semantic proximity Read ↗

Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial.Semantic proximity Read ↗

Acetylsalicylic Acid Suppresses Alcoholism-Induced Cognitive Impairment Associated with Atorvastatin Intake by Targeting Cerebral miRNA155 and NLRP3: In Vivo, and In Silico StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.